US 10494327
Controlled release pharmaceutical formulations
granted A61KA61K31/5575A61K31/558
Quick answer
US patent 10494327 (Controlled release pharmaceutical formulations) held by United Therapeutics Corporation expires Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United Therapeutics Corporation
- Grant date
- Tue Dec 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 28 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/5575, A61K31/558, A61P, A61P11/00